Clinical Trial Update: Study to Evaluate the Feasibility of Twice Daily Use of Topical Azelaic Acid in Breast Cancer Patients Undergoing Radiation [Phase 1]

View source ↗

Summary

A Phase 1 study updating on the feasibility of twice-daily topical azelaic acid for breast cancer patients undergoing radiation; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Azelaic acid (azelaic acid)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Breast Cancer | Phase 1 | Status: RECRUITING